BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15126608)

  • 1. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study.
    Sørensen HT; Mellemkjaer L; Nielsen GL; Baron JA; Olsen JH; Karagas MR
    J Natl Cancer Inst; 2004 May; 96(9):709-11. PubMed ID: 15126608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
    Jensen AØ; Thomsen HF; Engebjerg MC; Olesen AB; Friis S; Karagas MR; Sørensen HT
    Br J Cancer; 2009 Jan; 100(1):200-5. PubMed ID: 19034275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
    Frisch M; Hjalgrim H; Olsen JH; Melbye M
    Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-melanoma skin cancers and glucocorticoid therapy.
    Karagas MR; Cushing GL; Greenberg ER; Mott LA; Spencer SK; Nierenberg DW
    Br J Cancer; 2001 Sep; 85(5):683-6. PubMed ID: 11531252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 1996 Dec; 74(11):1847-50. PubMed ID: 8956805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer morbidity among Danish female pharmacy technicians.
    Hansen J; Olsen JH
    Scand J Work Environ Health; 1994 Feb; 20(1):22-6. PubMed ID: 8016595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma.
    Taskinen M; Ranki A; Pukkala E; Jeskanen L; Kaitila I; Mäkitie O
    Am J Med Genet A; 2008 Sep; 146A(18):2370-5. PubMed ID: 18698627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.
    Praestegaard C; Kjaer SK; Andersson M; Steding-Jensen M; Frederiksen K; Mellemkjaer L
    Breast Cancer; 2016 Nov; 23(6):908-916. PubMed ID: 26660140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of invasive cancers following basal cell skin cancer.
    Levi F; La Vecchia C; Te VC; Randimbison L; Erler G
    Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive drug therapy as a potentiator of skin tumours in five patients with lymphoma.
    Hill BH
    Australas J Dermatol; 1976 Aug; 17(2):46-8. PubMed ID: 1037366
    [No Abstract]   [Full Text] [Related]  

  • 18. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study.
    Friis S; Nielsen GL; Mellemkjaer L; McLaughlin JK; Thulstrup AM; Blot WJ; Lipworth L; Vilstrup H; Olsen JH
    Int J Cancer; 2002 Jan; 97(1):96-101. PubMed ID: 11774249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.